je.st
news
MannKind Price Target Cut to $4.00 by Analysts at MLV & Co.
2015-05-18 04:16:11| Biotech - Topix.net
The firm currently has a "hold" rating on the stock. MLV & Co.' s price target would suggest a potential upside of 0.13% from the company's current price.
Tags: co
price
cut
target
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||